Important Drug Info Flashcards
(122 cards)
1
Q
ativan onset
A
1-5 min iv; 15-30 min im
2
Q
ativan peak
A
15-20 min iv; 2 hr im
3
Q
ativan duration
A
6-8 hrs
4
Q
ativan adult dose
A
0.5mg-2mg IV or 1-4mg IM
5
Q
ativan pedi dose
A
0.05 mg/kg IV
6
Q
benzo precautions
A
additive effects with other CNS depressants, ETOH
7
Q
versed onset
A
3-5 min IV, 15 min IM
8
Q
versed peak
A
20-60 min
9
Q
versed duration
A
<2hrs IV, 1-6 hrs IM
10
Q
versed adult dose
A
2-5 mg IV/IM
11
Q
versed pedi dose
A
0.2 mg/kg slow IV
12
Q
albuterol onset
A
5-15 min
13
Q
albuterol peak
A
1-1.5 hrs
14
Q
albuterol duration
A
3-6 hrs
15
Q
albuterol contraindications
A
symptomatic tachycardia
16
Q
albuterol dose
A
2.5 mg in 2.5 mL
17
Q
albuterol interactions
A
b-blockers blunt effects, MAOI’s and TCA’s potentiate cardiovascular effects
18
Q
albuterol MOA
A
B2 agonist
19
Q
atrovent drug class
A
anticholinergic/parasympatholytic
20
Q
atrovent moa
A
muscarinic Ach-R blocker, dries resp. secretions
21
Q
atrovent onset
A
varies
22
Q
atrovent peak
A
1.5-2 hrs
23
Q
atrovent duration
A
4-6 hrs
24
Q
atrovent adult dose
A
500 mcg
25
atrovent pedi dose
250-500 mcg
26
mag sulfate drug class
mineral/antidysrhythmic
27
mag sulfate moa
physiological ca+ channel blocker, CNS depression, smooth muscle relaxation
28
mag onset
immediate IV
29
mag peak
varies
30
mag duration
1 hr
31
mag contraindications
3rd degree block, severe hypertension, impaired renal function, hypocalcemia
32
mag SE
flushing, sweating, bradycardia, resp. depression, dysrhythmias, hypotension
33
mag precautions
watch for resp. depression, have cacl2 available
34
mag interactions
digitalis
35
mag adult asthma dose
2g in 100cc NS over 10 min
36
mag adult VT, VF, Torsades (no pulse) dose
2g IV over 1-2 min
37
mag adult VT/torsades w/ pulse dose
1-2g in 50-100 CC NS over 5-60 min
38
mag eclampsia dose
2-4g over 25 min
39
mag pedi asthma dose
25-50 mg/kg over 15-30 min (max of 2g)
40
mag pedi VT no pulse dose
25-50 mg/kg IV (2g max)
41
mag pedi VT w/ pulse
25-50 mg/kg IV over 10-20 min (max 2g)
42
solu-medrol drug class
corticosteroid/immunosuppressant
43
solu-medrol onset
2-6 hrs
44
solu-medrol peak
4-8 days
45
solu-medrol duration
1-5 weeks
46
solu-medrol SE
Prolonged wound healing
47
solu-medrol adult dose
125mg
48
solu-medrol pedi dose
2mg/kg IV (max 80mg)
49
solu-medrol precautions
prolongs wound healing
50
solu-medrol interactions
lasix and thiazide diuretics increase K+ loss
51
nitro MOA
vasodilator, decreases preload and afterload
52
nitro onset
1-3 min SL
53
nitro peak
5-10 min SL
54
nitro duration
20-30 min SL
55
nitro contraindications
systolic under 100; R sided MI, ED drugs in past 48 hrs
56
nitro dose
0.4 mg SL q3-5 (max 3 doses or until systolic under 100)
57
nitro interactions
B-blockers cause orthostatic hypotension, ETOH causes severe hypotension
58
epi onset
<2 min IV; 3-10 min IM
59
epi peak
<5 min; 20 min IM
60
epi duration
5-10 min IV; 20-30 min IM
61
epi contraindications
HTN, tachydysrhythmias, pregnancy
62
epi interactions
deactivated by alkali, antidepressants intensify effects, forms PPT with CaCl2 and bicarb
63
aspirin moa
cox inhibitor, platelet aggregation inhibitor
64
aspirin onset
5-30 min
65
aspirin peak
15-120 min
66
aspirin duration
1-4 hrs
67
morphine onset
imm IV, 15-30 IM
68
morphine peak
20 min IV, 30-60 IM
69
morphine duration
2-7 hrs
70
morphine contraindications
hypotension/hypovolemia, COPD, hypersensitivity to morphine, codeine, percodan
71
morphine adult dose
2-10mg initial then 2mg q3-5min
72
morphine pedi dose
0.1mg/kg
73
morphine interactions
additive effects with CNS depression
74
zofran onset
10-30 min
75
zofran peak
unknown
76
zofran duration
unknown
77
zofran adult dose
4mg
78
zofran pedi dose
0.1mg/kg
79
adenosine drug class
class V antidysrhythmic
80
adenosine MOA
slow AV conduction
81
adenosine onset
imm.
82
adenosine peak
imm.
83
adenosine duration
30-45 sec
84
adenosine contraindications
2/3rd degree block, sick sinus syndrome, chemical induced SVT
85
adenosine adult dose
6mg then 12mg then 12mg
86
adenosine pedi dose
0.1mg/kg (max 6mg) then 0.2mg/kg (max 12mg)
87
epi moa
a1, b1, b2 agonist, blocks destruction of mast cells
88
epi drip dose
2-10 mcg/min
89
amiodarone class
class III, K+ channel blocker
90
amiodarone moa
prolongs cardiac action potential duration, refractory period
91
amiodarone onset
immed.
92
amiodarone SE
prolonged PR, QRS, QT intervals
93
amiodarone VT with pulse dose
150mg over 10 min
94
amiodarone pedi dose
5mg/kg, max 300mg
95
amiodarone VT w/ pulse pedi dose
5mg/kg over 20-60 min max 300mg
96
atropine moa
ach-r antagonist, parasympathetic inhibition; positive chronotropy but no inotropic effect
97
atropine onset
immed.
98
atropine peak
2-4 min
99
atropine duration
4 hrs
100
atropine bradycardia dose
.5 mg q3-5 min max 3mg
101
atropine RSI dose
.5-1mg
102
atropine OP OD dose
2-5 mg
103
atropine pedi bradycardia dose
0.02mg/kg min 0.1 max 0.5mg
104
atropine pedi RSI dose
0.02mg/kg
105
atropine OP OD dose pedi
0.02-0.05mg/kg
106
atropine contraindications
ineffective for 2nd degree type II/3rd degree blocks
107
atropine precautions
don't give less than 0.1mg (pedi) or 0.5mg (adult)
108
cardizem moa
slows av conduction, ca2+ channel blocker, decrease inotropy
109
cardizem onset
3min
110
cardizem duration
1-3 hrs
111
cardizem indications
rapid a-fib, a-flutter, PSVT refractory to adenosine
112
cardizem SE
N+V, dizziness, HA, bradycardia, heart block, hypotension, asystole
113
cardizem dose
15, 20, or 25mg
114
cardizem precautions
not for pedi!, may cause hypotension, have cacl2 available
115
cardizem contraindications
do not give to Pt's getting IV b blockers
116
calcium chloride moa
increases myocardial contractility and ventricular automaticity
117
cacl2 indications
hyperkalemia, hypocalcemia, ca+ channel blocker OD, crush syndrome, hypermagnesemia, CA due to suspected hyperkalemia
118
cacl2 SE
bradycardia, dysrhythmias, N+V, syncope, CA
119
cacl2 adult dose
500-1000mg
120
cacl2 pedi dose
20mg/kg
121
cacl2 precautions
tissue necrosis
122
cacl2 interactions
forms PPT with bicarb
